Related Experiment Video
Updated: Feb 12, 2026

Measuring Single-Cell Mitochondrial DNA Copy Number and Heteroplasmy Using Digital Droplet Polymerase Chain Reaction
Published on: July 12, 2022
Mitochondrial DNA mutations may contribute to aging via cell death caused by peptides that induce cytochrome c
Steven J Dubec1, Rajeev Aurora, H Peter Zassenhaus
1Department of Molecular Microbiology and Immunology, St Louis University School of Medicine, St Louis, MO 63104, USA.
Abstract:
Mice wherein the wild-type mitochondrial DNA polymerase (pol gamma) is replaced by a proofreading-deficient version are born with mutation frequencies in mitochondrial DNA (mtDNA) much higher than are ever normally seen in old rodents or humans. These mice, however, are phenotypically normal at birth, raising the question regarding how the much lower frequencies observed in normal aging could possibly contribute to the aging process. In contrast, transgenic mice with cardiac-specific expression of a proofreading-deficient poly gamma from birth onwards accumulate mtDNA mutations to levels normally seen in aging. But these mice develop dilated cardiomyopathy suggesting that age-related mtDNA mutations are pathogenic. Using computer simulation, we show that both findings are predicted based on the hypotheses that (1) rare lethal mutations that cause apoptosis underlie the pathogenesis of mutagenesis in mtDNA and (2) most sporadic mtDNA mutations are phenotypically recessive and therefore nonpathogenic. Biochemical evidence is presented that mitochondria with mtDNA mutations generate a peptide that causes the release of cytochrome c, providing a mechanism for the increased apoptosis observed in aging. Simulation also predicts that normal, age-related accumulation of mtDNA mutations causes significant levels of cell death. These findings suggest that mtDNA mutations play an important role in the aging process and that their pathogenic mechanism is linked to apoptosis.
Insights
Mitochondrial DNA (mtDNA) mutations accumulate with age and can cause cell death and disease. This study reveals how these mutations contribute to the aging process through apoptosis.
Area of Science:
- Mitochondrial biology
- Genetics
- Aging research
Background:
- Mitochondrial DNA (mtDNA) mutation frequencies increase with age, but their role in aging pathogenesis is unclear.
- Proofreading-deficient mtDNA polymerase leads to high mutation rates, yet mice are phenotypically normal at birth.
Purpose of the Study:
- To investigate the pathogenic role of age-related mtDNA mutations.
- To elucidate the mechanism by which mtDNA mutations contribute to aging and apoptosis.
Main Methods:
- Utilized genetically engineered mice with proofreading-deficient mitochondrial DNA polymerase (pol gamma).
- Employed computer simulations to model mutation accumulation and pathogenic effects.
- Presented biochemical evidence linking mtDNA mutations to apoptosis via cytochrome c release.
Main Results:
- Transgenic mice with cardiac-specific proofreading-deficient pol gamma developed dilated cardiomyopathy, indicating pathogenicity of mtDNA mutations.
- Computer simulations supported hypotheses that rare lethal mutations cause apoptosis and most mutations are recessive.
- Mitochondria with mtDNA mutations were shown to generate peptides inducing cytochrome c release, a key apoptosis factor.
Conclusions:
- Age-related mtDNA mutations are pathogenic and play a significant role in the aging process.
- The pathogenic mechanism of mtDNA mutations is linked to increased apoptosis.
- These findings provide a framework for understanding mtDNA mutagenesis and its contribution to aging.
More Related Videos
Related Concept Videos
Spontaneous and Induced Mutations
Export of Mitochondrial and Chloroplast Genes
Animal Mitochondrial Genetics
Peptide Bonds
Mutations
Overview of DNA Repair
Chemically...

